NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
79 hedge funds and large institutions have $84.4M invested in Navidea Biopharmaceuticals Inc. in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
96% less call options, than puts
Call options by funds: $368K | Put options by funds: $9.93M
Holders
79
Holding in Top 10
1
Calls
$368K
Puts
$9.93M
Top Buyers
| 1 | +$1.59M | |
| 2 | +$1.19M | |
| 3 | +$716K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$544K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$297K |
Top Sellers
| 1 | -$426K | |
| 2 | -$172K | |
| 3 | -$139K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$95.8K |
| 5 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$54.8K |